Norris Medicines Limited (NORRIS.BO)
INR 19.21
(-1.99%)
INR 19.21
(-1.99%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -11.86 Million INR | 32.17% |
| 2022 | -17.49 Million INR | 46.39% |
| 2021 | -32.63 Million INR | 34.23% |
| 2020 | -49.61 Million INR | -74.65% |
| 2019 | -28.41 Million INR | -69.47% |
| 2018 | -16.76 Million INR | 33.27% |
| 2017 | -25.12 Million INR | -227.43% |
| 2016 | -7.67 Million INR | -2127.21% |
| 2015 | 378.48 Thousand INR | 103.63% |
| 2014 | -10.43 Million INR | 28.17% |
| 2013 | -14.52 Million INR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -3.66 Million INR | -309.74% |
| 2023 Q1 | -6.14 Million INR | -13.08% |
| 2023 FY | -11.86 Million INR | 32.16% |
| 2023 Q4 | 1.74 Million INR | 164.55% |
| 2023 Q3 | -2.7 Million INR | 43.2% |
| 2023 Q2 | -4.76 Million INR | 22.56% |
| 2022 Q3 | -2.03 Million INR | 63.88% |
| 2022 FY | -17.49 Million INR | 46.39% |
| 2022 Q1 | -4.39 Million INR | 80.33% |
| 2022 Q2 | -5.63 Million INR | -28.21% |
| 2022 Q4 | -5.43 Million INR | -167.34% |
| 2021 FY | -32.63 Million INR | 34.23% |
| 2021 Q4 | -22.32 Million INR | -1092.14% |
| 2021 Q3 | -1.87 Million INR | 76.25% |
| 2021 Q2 | -7.88 Million INR | -1336.25% |
| 2021 Q1 | -549 Thousand INR | 98.27% |
| 2020 Q4 | -31.74 Million INR | -1211.21% |
| 2020 FY | -49.61 Million INR | -74.65% |
| 2020 Q3 | -2.42 Million INR | 81.27% |
| 2020 Q2 | -12.92 Million INR | -411.59% |
| 2020 Q1 | -2.52 Million INR | 54.08% |
| 2019 Q4 | -5.5 Million INR | 23.48% |
| 2019 FY | -28.41 Million INR | -69.47% |
| 2019 Q1 | -4.8 Million INR | -154.63% |
| 2019 Q2 | -10.91 Million INR | -127.4% |
| 2019 Q3 | -7.19 Million INR | 34.11% |
| 2018 Q1 | -8 Million INR | -888.32% |
| 2018 FY | -16.76 Million INR | 33.27% |
| 2018 Q4 | 8.78 Million INR | 191.21% |
| 2018 Q3 | -9.63 Million INR | -21.64% |
| 2018 Q2 | -7.92 Million INR | 1.0% |
| 2017 Q2 | -11.75 Million INR | -29.55% |
| 2017 FY | -25.12 Million INR | -227.43% |
| 2017 Q1 | -9.07 Million INR | -67.42% |
| 2017 Q4 | 1.01 Million INR | 119.89% |
| 2017 Q3 | -5.1 Million INR | 56.6% |
| 2016 Q3 | 392 Thousand INR | 185.59% |
| 2016 Q2 | -458 Thousand INR | 79.75% |
| 2016 Q1 | -2.26 Million INR | -190.57% |
| 2016 FY | -7.67 Million INR | -2127.21% |
| 2016 Q4 | -5.41 Million INR | -1482.59% |
| 2015 FY | 378.48 Thousand INR | 103.63% |
| 2015 Q3 | -2.63 Million INR | -285.7% |
| 2015 Q2 | 1.42 Million INR | 176.72% |
| 2015 Q1 | -1.85 Million INR | 80.2% |
| 2015 Q4 | 2.49 Million INR | 194.71% |
| 2014 Q1 | 450 Thousand INR | 0.0% |
| 2014 FY | -10.43 Million INR | 28.17% |
| 2014 Q2 | -1.01 Million INR | -324.89% |
| 2014 Q3 | -477 Thousand INR | 52.87% |
| 2014 Q4 | -9.34 Million INR | -1859.36% |
| 2013 FY | -14.52 Million INR | 0.0% |
| 2013 Q3 | 1.85 Million INR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 575.94 Thousand INR | 2160.541% |
| KIMIA BIOSCIENCES LIMITED | -53.08 Million INR | 77.645% |
| SHELTER PHARMA LIMITED | 62 Million INR | 119.141% |
| Vasundhara Rasayans Limited | 58.59 Million INR | 120.254% |
| Sunil Healthcare Limited | -17.88 Million INR | 33.646% |
| Chemo Pharma Laboratories Limited | 12 Million INR | 198.863% |
| MedPlus Health Services Limited | 654.73 Million INR | 101.813% |
| Bharat Immunologicals & Biologicals Corporation Limited | -166.38 Million INR | 92.868% |
| Patidar Buildcon Limited | -956 Thousand INR | -1141.371% |
| Roopa Industries Limited | 15.19 Million INR | 178.122% |
| Smruthi Organics Limited | 35.9 Million INR | 133.054% |
| Trident Lifeline Limited | 63.43 Million INR | 118.707% |
| PANJON LTD. | 1.51 Million INR | 883.64% |
| Pharmaids Pharmaceuticals Limited | -79.68 Million INR | 85.106% |
| Gujarat Terce Laboratories Limited | 2.43 Million INR | 587.572% |
| TIAAN CONSUMER LIMITED | -23.81 Million INR | 50.157% |
| Anuh Pharma Limited | 600.57 Million INR | 101.976% |
| Crestchem Limited | 21.46 Million INR | 155.292% |
| Emmessar Biotech & Nutrition Limited | 7.49 Million INR | 258.318% |
| Sandu Pharmaceuticals Limited | 14.61 Million INR | 181.218% |
| Tyche Industries Limited | 122.42 Million INR | 109.694% |
| Fredun Pharmaceuticals Limited | 156.23 Million INR | 107.596% |
| Trimurthi Limited | 104 Thousand INR | 11511.06% |
| Shukra Pharmaceuticals Limited | 185.37 Million INR | 106.402% |
| Zenlabs Ethica Limited | 4.21 Million INR | 381.755% |
| Vikram Thermo (India) Limited | 253.78 Million INR | 104.676% |
| ANG Lifesciences India Limited | -101.43 Million INR | 88.3% |
| Parmax Pharma Limited | -1.04 Million INR | -1040.36% |
| Veerhealth Care Limited | 4.06 Million INR | 392.303% |
| Deccan Health Care Limited | 14.92 Million INR | 179.509% |
| SUDARSHAN PHARMA INDUSTRIES LI | 114.55 Million INR | 110.36% |
| Makers Laboratories Limited | -62.64 Million INR | 81.055% |
| Lactose (India) Limited | 67.89 Million INR | 117.48% |
| OXYGENTA PHARMACEUTICAL LIMITE | -34.79 Million INR | 65.891% |
| Zenith Healthcare Limited | 2.03 Million INR | 683.17% |
| Sanjivani Paranteral Limited. | 61.65 Million INR | 119.249% |
| Bacil Pharma Limited | -590.53 Thousand INR | -1909.636% |
| PRAVEG LIMITED | 129.99 Million INR | 109.129% |
| Denis Chem Lab Limited | 111.55 Million INR | 110.638% |
| Kwality Pharmaceuticals Limited | 237.96 Million INR | 104.987% |
| Jenburkt Pharmaceuticals Limited | 259.77 Million INR | 104.568% |
| Colinz Laboratories Limited | 4.86 Million INR | 343.836% |
| Godavari Drugs Limited | 55.48 Million INR | 121.387% |
| SHAMROCK INDUSTRIAL CO.LTD. | -406 Thousand INR | -2823.03% |
| Zenotech Laboratories Limited | 82.98 Million INR | 114.3% |
| Panchsheel Organics Limited | 141.07 Million INR | 108.412% |
| Shree Ganesh Remedies Limited | 281.08 Million INR | 104.222% |
| Vivanza Biosciences Limited | 5.47 Million INR | 316.837% |
| Phaarmasia Limited | -5.18 Million INR | -129.014% |
| Sastasundar Ventures Limited | 88.82 Million INR | 113.36% |
| Medi-Caps Limited | -22.4 Million INR | 47.039% |
| DECIPHER LABS LIMITED | -16.75 Million INR | 29.175% |
| Gujarat Themis Biosyn Limited | 591.63 Million INR | 102.006% |
| Ambalal Sarabhai Enterprises Limited | 56.8 Million INR | 120.891% |
| Mercury Laboratories Limited | 56.54 Million INR | 120.989% |
| Gennex Laboratories Limited | 131.75 Million INR | 109.008% |
| BDH Industries Limited | 98.67 Million INR | 112.026% |
| Coral Laboratories Limited | 157.89 Million INR | 107.516% |
| Concord Drugs Limited | 4.72 Million INR | 351.217% |
| Bharat Parenterals Limited | 145.17 Million INR | 108.175% |
| Beryl Drugs Limited | 7.68 Million INR | 254.404% |
| Vista Pharmaceuticals Limited | -45.12 Million INR | 73.698% |
| Evoq Remedies Limited | 4.52 Million INR | 362.323% |
| Add-Shop E-Retail Limited | 31.57 Million INR | 137.59% |
| Transchem Limited | 42.03 Million INR | 128.233% |
| Ishita Drugs and Industries Limited | 7.48 Million INR | 258.55% |
| Parnax Lab Limited | 96.09 Million INR | 112.35% |
| Source Natural Foods and Herbal Supplements Limited | 17.36 Million INR | 168.342% |
| Kerala Ayurveda Limited | -15.27 Million INR | 22.287% |
| Cian Healthcare Limited | 2.54 Million INR | 566.673% |
| Trinity League India Limited | -27.07 Million INR | 56.162% |
| Syschem (India) Limited | 27.61 Million INR | 142.976% |
| KOBO BIOTECH LIMITED | -49.28 Million INR | 75.922% |
| Natural Capsules Limited | 55.53 Million INR | 121.369% |
| Auro Laboratories Limited | 77.92 Million INR | 115.23% |